Thomas D. Madden - Concepedia

Author

Thomas D. Madden

University of British Columbia

Also Known As

T D Madden, T. D. MADDEN, T. D. Madden, T. Madden, T.D. Madden, THOMAS D. MADDEN, Thomas D Madden, Thomas D. Madden

Publications

13.2K

Citations

H-Index

Concepts

All Affiliations

University of British Columbia Acuitas Therapeutics (Canada)University of Pennsylvania Alnylam Pharmaceuticals (United States)BC Cancer Agency

About

Thomas D. Madden is an author at University of British Columbia specializing in medicine, biochemistry, and pharmacology.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	23	31	6K
2	Biochemistry	17	21	2.1K
3	Natural Sciences	10	10	1.5K
4	Engineering	8	8	4.1K
5	Social Sciences	1	1	48

Thomas D. Madden

Publications

12.8K

Citations

H-Index

Page 1

	Year	Citations
Rational design of cationic lipids for siRNA delivery Sean C. Semple, Akin Akinc, Jianxin Chen, Nature Biotechnology Lipid PreparationNanomedicineEngineeringRational DesignGene Delivery	2010	1.7K
The Onpattro story and the clinical translation of nanomedicines containing nucleic acid-based drugs Akin Akinc, Martin A. Maier, Muthiah Manoharan, Nature Nanotechnology NanomedicineEngineeringClinical TranslationMedicineTheranostics	2019	1.5K
Maximizing the Potency of siRNA Lipid Nanoparticles for Hepatic Gene Silencing In Vivo** Muthusamy Jayaraman, Steven M. Ansell, Barbara L. Mui, Angewandte Chemie International Edition	2012	1.2K
Expression kinetics of nucleoside-modified mRNA delivered in lipid nanoparticles to mice by various routes Norbert Pardi, Steven Tuyishime, Hiromi Muramatsu, Journal of Controlled Release NanotherapeuticsBiochemistryNatural SciencesLipid NanoparticlesMolecular Biology	2015	980
Zika virus protection by a single low-dose nucleoside-modified mRNA vaccination Norbert Pardi, Michael J. Hogan, Rebecca S. Pelc, Nature VaccinationVaccinologyVaccine DevelopmentVaccine TargetZika Virus Protection	2017	872
Biodegradable Lipids Enabling Rapidly Eliminated Lipid Nanoparticles for Systemic Delivery of RNAi Therapeutics Martin A. Maier, Muthusamy Jayaraman, Shigeo Matsuda, Molecular Therapy	2013	594
Nucleoside-modified mRNA vaccines induce potent T follicular helper and germinal center B cell responses Norbert Pardi, Michael J. Hogan, Martin S. Naradikian, The Journal of Experimental Medicine	2018	501
Influence of Polyethylene Glycol Lipid Desorption Rates on Pharmacokinetics and Pharmacodynamics of siRNA Lipid Nanoparticles Barbara L. Mui, Ying K. Tam, Muthusamy Jayaraman, Molecular Therapy — Nucleic Acids Cell-based Drug DeliveryNanomedicineEngineeringChain LengthMedicine	2013	459
The Liposomal Formulation of Doxorubicin Sheela A. Abraham, Dawn Waterhouse, Lawrence D. Mayer, Methods in enzymology on CD-ROM/Methods in enzymology Lipid PreparationMedicinal ChemistryMedicineLiposomal FormulationLipid Chemistry	2005	413
Administration of nucleoside-modified mRNA encoding broadly neutralizing antibody protects humanized mice from HIV-1 challenge Norbert Pardi, Anthony Secreto, Xiaochuan Shan, Nature Communications	2017	331

Page 1